Thursday, September 17, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Markets

NVO43.05▼ 2.19%LLY1145.69▲ 2.02%HIMS27.77▲ 1.22%VKTX29.70▼ 7.58%AMGN381.14▼ 0.35%GPCR35.56▼ 10.08%ZEAL282.90▲ 1.69%PFE27.70▲ 0.16%AZN165.70▲ 3.80%RHHBY54.88▲ 3.18%NVO43.05▼ 2.19%LLY1145.69▲ 2.02%HIMS27.77▲ 1.22%VKTX29.70▼ 7.58%AMGN381.14▼ 0.35%GPCR35.56▼ 10.08%ZEAL282.90▲ 1.69%PFE27.70▲ 0.16%AZN165.70▲ 3.80%RHHBY54.88▲ 3.18%

Research

Operationalizing Alzheimer's disease trials in the era of targeted therapies

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026 Sep · Pillai JA, Alladi S, Appleby BS et

By Priya Raman · Science Reporter

Aug 31 20:00 ETSource: Alzheimer's & dementia : the journal of the Alzheimer's Association

From the source

Operationalizing Alzheimer's disease trials in the era of targeted therapies
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026 Sep · Pillai JA, Alladi S, Appleby BS et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42750195/